Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

NCT02958956 · clinicaltrials.gov ↗

COMPLETED

Status

236507

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2, Cancer

Interventions

DRUG: Pioglitazone

Sponsor

Takeda